Skip to main content

Pac Bio Proof-of-Concept Paper Topped Most-Read GenomeWeb Daily News Articles Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb Daily News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Nov. 21.
 
1) Pac Bio Publishes Proof-of-Concept Paper on Single-Molecule Sequencing Technology (from Nov. 20)
 
2) Illumina to Seek FDA Clearance, CLIA Certification in '09 (from Nov. 17)
 
3) ABI Shareholders Overwhelmingly Elect to Receive Cash in Merger (from Nov. 20)
 
4) Life Technologies, Bio-Rad to Join S&P Indexes (from Nov. 18)
 
5) International Cancer Genome Consortium Announces Eight New Projects (from Nov. 19)
 
The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.